Daqing Hartwell

Consultant, Europe
Healthcare

Dr. Daqing Hartwell has over 20 years of experience in the pharmaceutical industry working in M&A, licensing, and market intelligence.

Daqing worked for 8 years for UCB as Director of Business Development where she was integral in the acquisition of Celltech Group as well as several product licensing and joint venture transactions. Prior to UCB, Daqing worked in a leading market research and intelligence agency in the U.S. where she led the analysis of products and competitive landscapes for pharmaceutical clients. More recently, Daqing worked with several U.S. and European companies seeking to expand their footprint across Asia, helping them find acquisition targets and partners.

Daqing is a native Mandarin speaker with a BSc degree in Biochemistry from Fudan University. She has a PhD in Pathology from Boston University School of Medicine and conducted her post-doctoral fellowship at Harvard University School of Medicine.

Recent Transactions